Hepion Pharmaceuticals, Inc. (HEPA) stock
HEPAOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as CTRVP
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q/A on Nov 17, 2026Score 1/30
$0.10−0.00 (-1.45%)
Close on Oct 19, 2026Market cap $7.26MP/E –Yield –
Hepion Pharmaceuticals total assets
Total assets on the balance sheet at the end of each period.
Hepion Pharmaceuticals's total assets was $5.01M at Sep 30, 2026. For fiscal 2025 it was $3.07M, up 90.2% from the year before. Over ten years it grew 4.4% a year on average. The highest annual figure on record is $103.55M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.07M | +90.2% |
| FY2024 | Dec 31, 2024 | $1.61M | -91.1% |
| FY2023 | Dec 31, 2023 | $18.09M | -70.0% |
| FY2022 | Dec 31, 2022 | $60.24M | -41.8% |
| FY2021 | Dec 31, 2021 | $103.55M | +112.9% |
| FY2020 | Dec 31, 2020 | $48.65M | +136.0% |
| FY2019 | Dec 31, 2019 | $20.61M | +12.1% |
| FY2017 | Jun 30, 2017 | $18.38M | +40.3% |
| FY2016 | Jun 30, 2016 | $13.11M | +143.7% |
| FY2015 | Jun 30, 2015 | $5.38M | +168.7% |
| FY2014 | Jun 30, 2014 | $2.00M | +2207.4% |
| FY2013 | Jun 30, 2013 | $86.72K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Sep 30, 2026 | $5.01M | +33.8% |
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $1.93M | -57.2% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $2.71M | -57.2% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $3.07M | +90.2% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $3.74M | +0.7% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $4.51M | -25.0% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $6.32M | -60.5% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $1.61M | -91.1% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $3.72M | -85.1% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $6.01M | -83.5% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $15.99M | -67.7% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $18.09M | -70.0% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $25.00M | -64.1% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $36.50M | -56.3% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $49.50M | -48.4% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $60.24M | -41.8% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | $69.70M | -37.5% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | $83.57M | -30.2% |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | $95.86M | -22.5% |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | $103.55M | +112.9% |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | $111.60M | +448.0% |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | $119.75M | +397.2% |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | $123.76M | +431.8% |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | $48.65M | +136.0% |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | $20.36M | -3.4% |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | $24.08M | +3.2% |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | $23.27M | +194.4% |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | $20.61M | +12.1% |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | $21.07M | +79.2% |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | $23.34M | +45.3% |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | $7.90M | -10.3% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $18.38M | +40.3% |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $11.76M | +74.2% |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $16.07M | +50.9% |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $8.82M | +208.9% |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | $13.11M | +143.7% |
| Q3 FY2016CQ1 2016 | Mar 31, 2016 | $6.75M | – |
| Q2 FY2016CQ4 2015 | Dec 31, 2015 | $10.65M | – |
| Q1 FY2016CQ3 2015 | Sep 30, 2015 | $2.85M | – |
| Q4 FY2015CQ2 2015 | Jun 30, 2015 | $5.38M | – |
See a number that looks wrong?